China Oncology ›› 2015, Vol. 25 ›› Issue (10): 791-795.doi: 10.3969/j.issn.1007-3969.2015.10.006

Previous Articles     Next Articles

miR-101 inhibits growth and invasion of ovarian cancer cells by targeting DNMT3A

HU Keke, DENG Henan, TAN Chen, PENG Lixiu, XIAO Binmei   

  1. Department of Gynaecology and Obstetrics, First Hospital of Chenzhou, Chenzhou 423000, Hunan, China
  • Online:2015-10-30 Published:2015-12-17
  • Contact: HU Keke E-mail: zrzl67@aliyun.com

Abstract: Background and purpose: miR-101 has been reported to be down-regulated in gastric cancer, colorectal cancer, breast cancer as well as prostate cancer acting as a tumor suppressor gene. However, its function in ovarian cancer is still unknown. The aim of this study was to investigate whether miR-101 can suppress cell growth and invasion of ovarian cancer cells by targeting DNMT3A, so as to reveal molecular mechanism to inhibit ovarian cancer. Methods: Quantitative real-time palymerase chain reaction (qRT-PCR) method was employed to detect the expression of miR-101 in ovarian cancer and cancer adjacent normal ovarian tissues. SKOV3 cells were transfected with miR-101 mimics, and DNMT3A siRNA was transfected as a positive control. Then Western blot was used to detect the expression of DNMT3A protein regulated by miR-101 in SKOV3 cells. The growth and invasion ability of SKOV3 cells were evaluated by MTT and Transwell invasion assays. Results: qRT-PCR showed that miR-101 was down-regulated in ovarian cancer tissues. Western blot showed that the level of DNMT3A protein was inhibited by restored miR-101 or knock-down of DNMT3A in SKOV3 cells. Following transfection of miR-101 mimics or knock-down of DNMT3A for 48, 72 and 96 h respectively, MTT assay showed that the D values were significantly lower than the control group, (P<0.05). After transfection of miR-101 mimics or knock-down of DNMT3A for 36 h, Transwell invasion assay showed that the numbers of cells through the basement membrane was (105±7) and (107±13), respectively, which are significantly different from the control group (213±11), indicating invasion of SKOV3 cells significantly slowed down (P<0.05). Conclusion: miR-101 suppresses cell growth and invasion by targeting DNMT3A in ovarian cancer.

Key words: MiR-101, Ovarian cancer, DNMT3A, Growth and invasion